Skip to content
healthcare.dev
Get a free key

DARZALEX

NDC 57894-502, Daratumumab, injection, solution, concentrate, from Janssen Biotech, Inc..

Product NDC
57894-502
Status
Listed
Labeler
Janssen Biotech, Inc.
Dosage form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761036
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/57894-502 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DARATUMUMAB100 mg/5mL

Pharmacologic classes

Antibodies, Monoclonal [CS]; CD38-directed Antibody Interactions [MoA]; CD38-directed Cytolytic Antibody [EPC]

Package NDCNDC-11Package

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a4d0efe9-5e54-467e-9eb4-56fa7d53b60b

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=57894-502

Use it

Look up 57894-502 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/57894-502 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 57894-502. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.